Status:
NOT_YET_RECRUITING
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
Lead Sponsor:
Assiut University
Collaborating Sponsors:
Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
Conditions:
ITP - Immune Thrombocytopenia
Eligibility:
All Genders
18-75 years
Brief Summary
1. Assesement of response to Thrombopoietin receptor agonists (TPO-RAs) as treatment in Idiopathic thrombocytopenia purpura patients in Assiut University hospital. 2. Explore side effects of Thrombopo...
Detailed Description
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by reduced platelet counts (\<100 × 109/L) and increased bleeding risk in the absence of other causes associated with ...
Eligibility Criteria
Inclusion
- Patients presented with Idiopathic thrombocytopenic purpura (ITP)
- patients above age of 18 years.
Exclusion
- patients below age of 18 years .
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06137105
Start Date
December 1 2023
End Date
December 1 2026
Last Update
November 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.